Azzad Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$261K Buy
521
+24
+5% +$11.5K 0.02% 336
2026
Q1
$244K Buy
497
+1
+0.2% +$543 0.02% 316
2025
Q4
$287K Buy
496
+58
+13% +$32.8K 0.03% 308
2025
Q3
$212K Buy
+438
New +$204K 0.02% 317
2024
Q2
Sell
-2,923
Closed -$1.7M 316
2024
Q1
$1.7M Buy
2,923
+4
+0.1% +$2.25K 0.2% 183
2023
Q4
$1.55M Buy
2,919
+22
+0.8% +$10.6K 0.2% 183
2023
Q3
$1.47M Sell
2,897
-8
-0.3% -$4.26K 0.21% 178
2023
Q2
$1.52M Buy
2,905
+90
+3% +$48.6K 0.2% 176
2023
Q1
$1.62M Buy
2,815
+52
+2% +$29.3K 0.23% 172
2022
Q4
$1.52M Sell
2,763
-173
-6% -$91.7K 0.24% 162
2022
Q3
$1.48M Sell
2,936
-650
-18% -$364K 0.15% 201
2022
Q2
$1.93M Buy
3,586
+134
+4% +$73.8K 0.19% 171
2022
Q1
$2.04M Buy
3,452
+174
+5% +$100K 0.29% 133
2021
Q4
$2.19M Buy
3,278
+8
+0.2% +$5K 0.29% 132
2021
Q3
$1.87M Buy
3,270
+93
+3% +$51K 0.28% 145
2021
Q2
$1.6M Buy
+3,177
New +$1.5M 0.24% 166

Other funds holding TMO

Azzad Asset Management's TMO Position: Q2 2026 in Review

Azzad Asset Management increased its Thermo Fisher Scientific (TMO) stake by 4.8% in Q2 2026, buying an estimated $11.5K and bringing the position to 521 shares worth $261K. The position accounts for 0.02% of the portfolio, ranked #336.

Azzad Asset Management first reported a position in TMO in Q2 2021 and has held it in 16 quarters since. The position peaked at $2.19M in Q4 2021. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Azzad Asset Management held 521 shares of Thermo Fisher Scientific worth $261K as of Q2 2026.
  • Azzad Asset Management bought 24 Thermo Fisher Scientific shares in Q2 2026, an estimated $11.5K.
  • Thermo Fisher Scientific made up 0.02% of Azzad Asset Management's portfolio in Q2 2026, its #336 holding.
  • Azzad Asset Management first reported a position in Thermo Fisher Scientific in Q2 2021 and has held it in 16 quarters since.
  • Azzad Asset Management's Thermo Fisher Scientific position peaked at $2.19M in Q4 2021.
  • 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Azzad Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.